The mfr was notified on (b)(4) 2014 with a email from the hosp that of a mitroflow valve (lxa size 19) that was explanted after 1 year and 7 months due a reported high gradient secondary to an early structural valve deterioration in a young pt.On (b)(6) 2014, on the journal "circulation: the following article was published "accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults".On the list of pts that received a mitroflow valve and experimented the mitroflow explant, the mfr identified that the pt died after the explantation of the mitroflow valve.No details of the cause of death were provided.
|
Device eval by mfr: sorin received the explanted valve, the investigation is still ongoing.Eval, method = the results of the device history record review confirmed the device met all material, dimensional, and performance requirements at the time of mfr and release.Results = no definitive results at this time.No conclusion can be drawn at this time as the histological analysis is still ongoing.Corrected date: the following boxes were modified for correction.
|